Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY – Prenetics Global (NASDAQ:PRE)
Prenetics Global Limited reported full-year 2025 revenue of $92.4 million, a 480% increase from the prior year, powered by its IM8 health brand hitting $120 million in annual recurring revenue within 12 months of launch. The NASDAQ-listed company also posted $36.6 million in fourth-quarter sales.